Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
Pharmacogenomic (PGx) evidence for selective serotonin reuptake inhibitors (SSRIs) continues to evolve. For sites offering testing, maintaining up-to-date interpretations and implementing new clinical decision support (CDS) driven by existing results creates practical and technical challenges. Vande...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/59b4c678d0c74fe7be7ea8ccb90969b1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!